Literature DB >> 25178408

Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Deepika Suri1, Cátia M Teixeira1, Martha K Caffrey Cagliostro1, Darshini Mahadevia1, Mark S Ansorge2.   

Abstract

Development passes through sensitive periods, during which plasticity allows for genetic and environmental factors to exert indelible influence on the maturation of the organism. In the context of central nervous system development, such sensitive periods shape the formation of neurocircuits that mediate, regulate, and control behavior. This general mechanism allows for development to be guided by both the genetic blueprint as well as the environmental context. While allowing for adaptation, such sensitive periods are also vulnerability windows during which external and internal factors can confer risk to disorders by derailing otherwise resilient developmental programs. Here we review developmental periods that are sensitive to monoamine signaling and impact adult behaviors of relevance to psychiatry. Specifically, we review (1) a serotonin-sensitive period that impacts sensory system development, (2) a serotonin-sensitive period that impacts cognition, anxiety- and depression-related behaviors, and (3) a dopamine- and serotonin-sensitive period affecting aggression, impulsivity and behavioral response to psychostimulants. We discuss preclinical data to provide mechanistic insight, as well as epidemiological and clinical data to point out translational relevance. The field of translational developmental neuroscience has progressed exponentially providing solid conceptual advances and unprecedented mechanistic insight. With such knowledge at hand and important methodological innovation ongoing, the field is poised for breakthroughs elucidating the developmental origins of neuropsychiatric disorders, and thus understanding pathophysiology. Such knowledge of sensitive periods that determine the developmental trajectory of complex behaviors is a necessary step towards improving prevention and treatment approaches for neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25178408      PMCID: PMC4262911          DOI: 10.1038/npp.2014.231

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  428 in total

Review 1.  Sensitive periods in the development of the brain and behavior.

Authors:  Eric I Knudsen
Journal:  J Cogn Neurosci       Date:  2004-10       Impact factor: 3.225

2.  Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.

Authors:  O Giorgi; G De Montis; M L Porceddu; S Mele; G Calderini; G Toffano; G Biggio
Journal:  Brain Res       Date:  1987-10       Impact factor: 3.252

3.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Authors:  Cornelius Gross; Xiaoxi Zhuang; Kimberly Stark; Sylvie Ramboz; Ronald Oosting; Lynn Kirby; Luca Santarelli; Sheryl Beck; René Hen
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

4.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

5.  Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory.

Authors:  Catherine A Hartley; Morgan C McKenna; Rabia Salman; Andrew Holmes; B J Casey; Elizabeth A Phelps; Charles E Glatt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

6.  Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development.

Authors:  A L Upton; N Salichon; C Lebrand; A Ravary; R Blakely; I Seif; P Gaspar
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

7.  Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder.

Authors:  A Raine; T Lencz; S Bihrle; L LaCasse; P Colletti
Journal:  Arch Gen Psychiatry       Date:  2000-02

8.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.

Authors:  Jan Volavka; Pal Czobor; Karen Nolan; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Thomas B Cooper; Jeffrey A Lieberman
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

10.  Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex.

Authors:  A M Thierry; C Le Douarin; J Penit; A Ferron; J Glowinski
Journal:  Brain Res Bull       Date:  1986-02       Impact factor: 4.077

View more
  55 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

2.  The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When?

Authors:  Jonathan Posner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-11       Impact factor: 8.829

3.  Effect of Early-Life Fluoxetine on Anxiety-Like Behaviors in BDNF Val66Met Mice.

Authors:  Iva Dincheva; Jianmin Yang; Anfei Li; Tina Marinic; Helena Freilingsdorf; Chienchun Huang; B J Casey; Barbara Hempstead; Charles E Glatt; Francis S Lee; Kevin G Bath; Deqiang Jing
Journal:  Am J Psychiatry       Date:  2017-10-31       Impact factor: 18.112

4.  Neurodevelopment and the origins of brain disorders.

Authors:  Pat Levitt; Jeremy Veenstra-VanderWeele
Journal:  Neuropsychopharmacology       Date:  2015-01       Impact factor: 7.853

5.  Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype.

Authors:  Edênia C Menezes; Relish Shah; Lindsay Laughlin; K Yaragudri Vinod; John F Smiley; Catarina Cunha; Andrea Balla; Henry Sershen; Francisco X Castellanos; André Corvelo; Cátia M Teixeira
Journal:  J Neurosci       Date:  2021-02-03       Impact factor: 6.167

6.  Enhancement of Aggression Induced by Isolation Rearing is Associated with a Lack of Central Serotonin.

Authors:  Yiqiong Liu; Yunong Sun; Xiaoyan Zhao; Ji-Young Kim; Lu Luo; Qian Wang; Xiaolu Meng; Yonghui Li; Nan Sui; Zhou-Feng Chen; Chuxiong Pan; Liang Li; Yan Zhang
Journal:  Neurosci Bull       Date:  2019-04-11       Impact factor: 5.203

Review 7.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

Review 8.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

9.  Serotonin increases synaptic activity in olfactory bulb glomeruli.

Authors:  Julia Brill; Zuoyi Shao; Adam C Puche; Matt Wachowiak; Michael T Shipley
Journal:  J Neurophysiol       Date:  2015-12-09       Impact factor: 2.714

10.  Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors.

Authors:  Anne Teissier; Alexei Chemiakine; Benjamin Inbar; Sneha Bagchi; Russell S Ray; Richard D Palmiter; Susan M Dymecki; Holly Moore; Mark S Ansorge
Journal:  Cell Rep       Date:  2015-11-19       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.